Using the monocyte activation test as a stand-alone release test for medical devices
ALTEX · 2021 · 151-156
DOI: 10.14573/altex.2012021 ↗Kurz gefasst
Editorial in der Zeitschrift ALTEX, 2021. Verfasst von Jeffrey Brown und 17 weiteren Autor:innen. Beteiligte Einrichtung: PETA International Science Consortium Ltd., London, United Kingdom. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Monocyte activation tests (MAT) are widely available but rarely used in place of animal-based pyrogen tests for safety assessment of medical devices. To address this issue, the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods and the PETA International Science Consortium Ltd. convened a workshop at the National Institutes of Health on September 18-19, 2018. Participants included representatives from MAT testing laboratories, medical device manufacturers, the U.S. Food and Drug Administration’s Center for Devices and Radiologic Health (CDRH), the U.S. Pharmacopeia, the International Organization for Standardization, and experts in the development of MAT protocols. Discussions covered industry experiences with the MAT, remaining challenges, and how CDRH’s Medical Device Development Tools (MDDT) Program, which qualifies tools for use in evaluating medical devices to streamline device development and regulatory evaluation, could be a pathway to qualify the use of MAT in place of the rabbit pyrogen test and the limulus amebocyte lysate test for medical device testing. Workshop outcomes and follow-up activities are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PETA International Science Consortium Ltd., London, United Kingdom.
- Vedere Solutions LLC, Erie, USA.
- National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, Durham, USA.
- Medtronic, Minneapolis, USA.
- Confarma, Hombourg, France.
- Johns Hopkins Bloomberg School of Public Health, CAAT, Baltimore, USA.
Zitieren
APA
Brown, J., Clippinger, A. J., Fritz Briglia, C., Casey, W., Coleman, K., Fritsch, A., Hartung, T., Maouyo, D., Muller, T., Reich, J., Robert, L., Roeder, R., Sanchez, G., Sawyer, A. Y., Solati, S., Tirumalai, R., Zwisler, W., & Allen, D. (2021). Using the monocyte activation test as a stand-alone release test for medical devices. ALTEX, 151-156. https://doi.org/10.14573/altex.2012021
Vancouver
Brown J, Clippinger AJ, Fritz Briglia C, Casey W, Coleman K, Fritsch A, et al. Using the monocyte activation test as a stand-alone release test for medical devices. ALTEX. 2021:151-156. doi:10.14573/altex.2012021
BibTeX
@article{Brown2021,
author = {Brown, Jeffrey and Clippinger, Amy J and Fritz Briglia, Claire and Casey, Warren and Coleman, Kelly and Fritsch, Anja and Hartung, Thomas and Maouyo, Djik and Muller, Thierry and Reich, Johannes and Robert, Laure and Roeder, Ruth and Sanchez, Guillermo and Sawyer, Anita Y and Solati, Shabnam and Tirumalai, Radhakrishna and Zwisler, Walter and Allen, David},
title = {Using the monocyte activation test as a stand-alone release test for medical devices},
journal = {ALTEX},
year = {2021},
pages = {151--156},
doi = {10.14573/altex.2012021}
}
EUVIMED